Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Astria Therapeutics, Inc. (ATXS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -49.0-47.7-51.8-48.1-43.9-64.6-219.3-218.8
Stock-based compensation  4.84.64.64.54.34.23.42.7
Change in working capital   [+]-0.6-1.32.12.40.60.5-3.2-4.5
Other operating activities  0.00.21.72.12.325.9189.0188.7
Cash from operations  -44.9-44.2-43.5-39.2-36.7-34.0-30.2-31.9
   
Capital expenditures  -0.1-0.1-0.1-0.10.00.00.00.0
Purchases of short-term investments, net  3.955.1-167.0-70.9-72.9-66.1-19.0 
Cash from investing  3.855.0-167.1-70.9-72.9-66.1-12.66.4
   
Issuance of common stock, net    107.6     
Option exercises  0.40.10.10.1  0.00.0
Other cash from financing  37.837.237.224.4  0.00.0
Cash from financing  145.0144.8144.724.30.00.0104.3104.3
   
Free cash flow  -45.0-44.3-43.6-39.2-36.7-34.0-30.2-32.0
        Per share (diluted)  ($2.13)($2.56)($3.21)($3.22)($3.07)($3.34)($3.84)($4.99)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy